Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 24;23(3):1278.
doi: 10.3390/ijms23031278.

Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues

Affiliations

Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues

Marta Zola et al. Int J Mol Sci. .

Abstract

Central serous chorioretinopathy (CSCR) is a retinal disease affecting the retinal pigment epithelium (RPE) and the choroid. This is a recognized side-effect of glucocorticoids (GCs), administered through nasal, articular, oral and dermal routes. However, CSCR does not occur after intraocular GCs administration, suggesting that a hypothalamic-pituitary-adrenal axis (HPA) brake could play a role in the mechanistic link between CSCR and GS. The aim of this study was to explore this hypothesis. To induce HPA brake, Lewis rats received a systemic injection of dexamethasone daily for five days. Control rats received saline injections. Baseline levels of corticosterone were measured by Elisa at baseline and at 5 days in the serum and the ocular media and dexamethasone levels were measured at 5 days in the serum and ocular media. The expression of genes encoding glucocorticoid receptor (GR), mineralocorticoid receptors (MR), and the 11 beta hydroxysteroid dehydrogenase (HSD) enzymes 1 and 2 were quantified in the neural retina and in RPE/ choroid. The expression of MR target genes was quantified in the retina (Scnn1A (encoding ENac-α, Kir4.1 and Aqp4) and in the RPE/choroid (Shroom 2, Ngal, Mmp9 and Omg, Ptx3, Plaur and Fosl-1). Only 10% of the corticosterone serum concentration was measured in the ocular media. Corticosterone levels in the serum and in the ocular media dropped after 5 days of dexamethasone systemic treatment, reflecting HPA axis brake. Whilst both GR and MR were downregulated in the retina without MR/GR imbalance, in the RPE/choroid, both MR/GR and 11β-hsd2/11β-hsd1 ratio increased, indicating MR pathway activation. MR-target genes were upregulated in the RPE/ choroid but not in the retina. The psychological stress induced by the repeated injection of saline also induced HPA axis brake with a trend towards MR pathway activation in RPE/ choroid. HPA axis brake causes an imbalance of corticoid receptors expression in the RPE/choroid towards overactivation of MR pathway, which could favor the occurrence of CSCR.

Keywords: central serous chorioretinopathy; glucocorticoid; mineralocorticoid; retina.

PubMed Disclaimer

Conflict of interest statement

MZ, FBC and FJ are cited as inventors in patents protecting the use of mineralocorticoid receptor antagonists in the treatment of CSCR.

Figures

Figure 1
Figure 1
Corticosterone and dexamethasone levels in the rat serum and ocular media. Corticosterone in the serum (A) and ocular media (B) at baseline (n = 7) and after 5 days of daily injection of dexamethasone (D5) (n = 16) or saline (n = 5). Spearman correlation between corticosterone ocular and serum levels (r = 0.76, p = 0.0001) (C). Dexamethasone serum (n = 14) and ocular media (n = 7) after 5 days of daily injection of dexamethasone (D). Spearman correlation between dexamethasone ocular and serum levels (r = −0.28, p = 0.55) (E), ** p < 0.001, *** p < 0.0001, ns non significant.
Figure 2
Figure 2
Corticoid receptors and hydroxysteroid dehydrogenase gene expression in the retina and RPE/choroid. (A) neural retina: Nr3c1, encoding GR, Nr3c2 encoding MR and 11β-hsd1 and 2 expression at baseline (n = 7), after 5 days of daily injection of dexamethasone (n = 16), or saline (n = 6); (B) RPE/choroid: Nr3c1, encoding GR, Nr3c2 encoding MR and 11β-hsd1(HSD1) and 2 (HSD2) expression at baseline (n = 7), after 5 days of daily injection of dexamethasone (n = 16), or saline (n = 6), * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Figure 3
Figure 3
Corticoid receptors and hydroxysteroid dehydrogenase gene expression in the iris/ciliary body. Nr3c1, encoding GR, Nr3c2 encoding MR and 11β-hsd1 and 2 expression at baseline (n = 7), after 5 days of daily injection of dexamethasone (n = 16), or saline (n = 6), * p < 0.05, ** p < 0.01.
Figure 4
Figure 4
Regulation of MR-induced genes in the neural retina. Scnn1A encoding ENac-α Kir4.1 and Aqp4 expression at baseline (n = 7), after 5 days of daily injection of dexamethasone (n = 16), or saline (n = 6), * p < 0.05, *** p < 0.001.
Figure 5
Figure 5
Regulation of MR-induced genes in the RPE/choroid. Expression of Shroom 2, Ngal, Mmp9 and Omg, Ptx3, Plaur and Fosl-1 in the RPE/choroid of rats at baseline (n = 7), after 5 days of daily injection of dexamethasone (n = 16) or saline (n = 6), * p < 0.05, ** p < 0.01.
Figure 6
Figure 6
Schematic representation of the ocular consequences of HPA axis brake on ocular GR/MR pathways [34,49,61].
Figure 7
Figure 7
Schematic representation of the experiments. Serum was extracted from blood samples, intraocular fluids include aqueous humour and vitreous from each eye. Ocular tissue dissection separated the iris-ciliary body complex, the neural retina, the retinal pigment epithelium (RPE)-choroid complex or each eye separately.

References

    1. Aliotta N. ACTH and cortisone, dangerous weapons. Clin. Nuova Rass. Prog. Med. Int. 1952;14:1–4. - PubMed
    1. Lan N.C., Graham B., Bartter F.C., Baxter J.D. Binding of Steroids to Mineralocorticoid Receptors: Implications for in Vivo Occupancy by Glucocorticoids. J. Clin. Endocrinol. Metab. 1982;54:332–342. doi: 10.1210/jcem-54-2-332. - DOI - PubMed
    1. Campen T.J., Vaughn D.A., Fanestil D.D. Mineralo- and Glucocorticoid Effects on Renal Excretion of Electrolytes. Pflug. Arch. 1983;399:93–101. doi: 10.1007/BF00663903. - DOI - PubMed
    1. Grossmann C., Scholz T., Rochel M., Bumke-Vogt C., Oelkers W., Pfeiffer A.F.H., Diederich S., Bahr V. Transactivation via the Human Glucocorticoid and Mineralocorticoid Receptor by Therapeutically Used Steroids in CV-1 Cells: A Comparison of Their Glucocorticoid and Mineralocorticoid Properties. Eur. J. Endocrinol. 2004;151:397–406. doi: 10.1530/eje.0.1510397. - DOI - PubMed
    1. Baxter J.D., Funder J.W., Apriletti J.W., Webb P. Towards Selectively Modulating Mineralocorticoid Receptor Function: Lessons from Other Systems. Mol. Cell. Endocrinol. 2004;217:151–165. doi: 10.1016/j.mce.2003.10.044. - DOI - PubMed

MeSH terms